Chargement en cours...
Inhibitors targeting CDK4/6, PARP and PI3K in breast cancer: a review
Breast cancer is the global leading cause of cancer-related death in women and it represents a major health burden worldwide. One of the promising breast cancer therapeutic avenues is through small molecule inhibitors (SMIs) which have undergone rapid progress with successful clinical trials. Recent...
Enregistré dans:
| Publié dans: | Ther Adv Med Oncol |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
SAGE Publications
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6236629/ https://ncbi.nlm.nih.gov/pubmed/30542378 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835918808509 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|